Annonacin in Asimina triloba fruit : implications for neurotoxicity. by Potts, Lisa Fryman
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Electronic Theses and Dissertations 
12-2011 
Annonacin in Asimina triloba fruit : implications for neurotoxicity. 
Lisa Fryman Potts 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/etd 
Recommended Citation 
Potts, Lisa Fryman, "Annonacin in Asimina triloba fruit : implications for neurotoxicity." (2011). Electronic 
Theses and Dissertations. Paper 1145. 
https://doi.org/10.18297/etd/1145 
This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's 
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized 
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the 
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu. 
ANNONACIN IN ASIMINA TRILOBA FRUIT: 
IMPLICATIONS FOR NEUROTOXICITY 
8y 
Lisa Fryman Potts 
8.S. Centre College, 2005 
M.S. University of Louisville, 2010 
A Dissertation 
Submitted to the Faculty of the 
School of Medicine 
at the University of Louisville 
in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
Department of Anatomical Sciences and Neurobiology 
University of Louisville 
School of Medicine 
Louisville, Kentucky 
December 2011 
Copyright 2011 by lisa Fryman Potts 






ANNONACIN IN ASIMINA TRILOBA FRUIT: 




Lisa Fryman Potts 
B.S. Centre College, 2005 
M.S. University of Louisville, 2010 
 
 
A Dissertation Approved on 
 
July 21, 2011 
 




       




       
Frederick Luzzio, Ph.D. 
 
 
       
Michal Hetman, M.D., Ph.D. 
 
 
       
David Hein, Ph.d. 
 
 
       
Theo Hagg, Ph.D. 
 
 
       
Martha Bickford, Ph.D. 
DEDICATION 
This dissertation is dedicated to my parents 
Mr. Harry Fryman 
and 
Mrs. Linda Fryman 
and my husband 
Mr. Joseph Potts 
who have supported me throughout my academic career and life 
iii 
ACKNOWLEDGEMENTS 
I would like to thank my mentor, Dr. Irene Litvan for her guidance and 
support. I would also like to thank Dr. Frederick Luzzio and Dr. Michal Hetman 
for their support and mentorship on specific aspects of this research. I also thank 
my other committee members, Dr. David Hein, Dr. Theo Hagg and Dr. Martha 
Bickford for their support and guidance during my graduate career at the 
University of Louisville. I would also like to thank Dr. Pierre Champy for sample 
donation and consultation, Ms. Juan Chen and Dr. Bogdan Bogdanov for their 
technical assistance, as well as Mr. Scott Smith for his technical assistance and 
moral support. I would also like to express my appreciation to Dr. Samuel 
Weakly and Ms. Lydia B. Miller for their generosity in donating research funds 
that supported this project. 
iv 
ABSTRACT 
ANNONACIN IN ASIMINA TRILOBA FRUIT: 
IMPLICATIONS FOR NEUROTOXICITY 
Lisa F. Potts 
November 28, 2011 
The acetogenin annonacin, from the tropical annonaceous plant Annona 
muricata, is a lipophilic, mitochondrial complex I inhibitor reported to be more 
toxic than rotenone to mesencephalic neurons. The temperate annonaceous 
plant Asimina tri/oba (pawpaw) is native to the Eastern United States and its 
products are available online. This study determined whether annonacin is in the 
pawpaw fruit pulp and whether it or the crude ethyl acetate (EtOAc) extract is 
toxic to cortical neurons and induces pathological changes in the microtubule 
associated protein tau. 
Pawpaw extract was prepared by pulp extraction with methanol and liquid-
liquid partitioning with EtOAc. Annonacin was isolated from the crude EtOAc 
extract via column chromatography using a gradient solvent system of increasing 
polarity. Mass spectroscopy, nuclear magnetic resonance and infrared 
v 
spectroscopy were used to compare isolated material with synthetic annonacin 
and a natural annonacin sample. Toxicity of isolated annonacin and the total 
EtOAc extract were determined in primary rat cortical neurons using the MIT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The effects of 
annonacin on tau phosphorylation were determined by immunocytochemistry and 
western blot analysis. 
The average concentration of annonacin in the fruit pulp was 0.07 ± 0.03 
mg/g. Purified annonacin (30.07 !-Ig/ml) and crude EtOAc extract (47.96 !-I9/ml) 
reduced relative viability of cortical neurons by 50% 48 hours post treatment. 
Annonacin toxicity was enhanced in the presence of crude extract. Annonacin 
treatment resulted in a decrease in the neuronal specific marker microtubule 
associated protein 2 (MAP2) and tau immunoreactivity, and tau expression was 
decreased on western blot. 
In conclusion, Asimina triloba fruit contains a high concentration of 
annonacin, which is toxic to cortical neurons. Based on these results, annonacin 
acts to reduce overall levels of tau, though it remains elusive whether or not this 
is a direct or indirect effect of annonacin action. Crude fruit extract also induced 
neurotoxicity, highlighting the need for additional studies to determine the 
bioavailability after consumption and potential risks of neurodegeneration 
associated with chronic exposure to pawpaw products. 
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Annonaceous acetogenins (ACGs), specifically annonacin, isolated from 
Annona muricata (An. muricata) fruit, bark and leaves are naturally occurring 
compounds exhibiting a range of biological activities related to inhibition of 
mitochondrial complex I of the electron transport chain.1-4 The annonaceous 
plants have been investigated for their potential as cancer treatments,5-8 but also 
for neurotoxicity due to their high content of acetogenins.9. 10 The purpose of this 
project was to determine the presence and quantity of annonacin in Asimina 
triloba (As. triloba) fruit pulp and assess annonacin and crude extract toxicity in 
cultured cortical neurons, which are affected in a number of neurodegenerative 
diseases. 
Annonaceous Plants 
The Annonaceae, or custard-apple, family consists of many different 
genera including Annona and Asimina, each containing several species. The 
United States Department of Agriculture provides a complete list of the 205 
Annonaceae genera on the Germplasm Resources Information Network (GRIN, 
1 
http://www.ars-grin.gov/cgi-bin/npgs/html/exgnlist.pl) including Annona (89) and 
Asimina (12) individual species taxonomy. Most annonaceous plants are 
confined to tropical or sub-tropical climates; however, the Asimina species are 
also tolerant of temperate climates.8 
Figure 1. Asimina tri/oba (pawpaw) tree 
at the University of Kentucky Arboretum in 
Lexington, KY (2008). 
2 
Specifically, As. triloba (Figure 1. pawpaw, papaw, prairie banana, poor 
man's banana, dog banana, Ozark banana, Banango, also commonly referred to 
as its native states "banana" e.g. Indiana/Hoosier banana, Kentucky banana) is 
native to the Eastern United States and even southern parts of Canada making it 
the only fruit-bearing annonaceous plant found abundantly throughout North 
America (Figure 2). 
The Annonaceae are widely studied due to their high concentrations of 
cytotoxic alkaloids and acetogenins, which may be useful as anti-cancer, anti-
fungal , anti-viral , and pesticidal agents. 3, 11-13 Annona muricata (Figure 3. An. 
muricata, soursop, graviola, guanabana, Brazilian pawpaw, prickly custard apple) 
is particularly well known for its medicinal use as an anti-cancer agent.?' 14 
Recently, graviola was even featured on the popular Dr. Oz show for its 
immunity-boosting properties http://www.doctoroz.com/videos/rainforest-
remedies-pt-2 , May 23, 2011 ). As. triloba is also growing in popularity for its 
potential use in alternative medicine and is being promoted for development as 
an alternative cash crop to tobacco in some states. 15, 16 
3 
Figure 2. Distribution of As. triloba in North America. Map and related 
information from the United States department of agriculture natural resources 
conservation services is available online at http://plants.usda.gov. 
4 




ACGs are a class of polyketide compounds containing, in most cases, a 
long hydrocarbon chain and a terminaly-Iactone moiety (i.e. butenolide). Most 
ACGs contain one or more tetrahydrofuran (THF) rings, (see Table 1 for a brief 
list of bioactive annonaceous acetogenins). However, there are some without a 
THF ring that may contain tetrahydropyran (THP) or epoxy rings or that are 
linear.1 They are reported to be cytotoxic via mitochondrial complex-1 inhibition 
5 
and adenosine triphosphate (ATP) depletion.8 Acetogenins can be found in 
various organs of annonaceous plants, with seeds and bark having historically 
been the most commonly studied. However, recent research on ACG content of 
the Annonaceae has investigated the fruit with reports of acetogenins in both 
soursop (Figure 4) and pawpaw (Figure 5) fruit pulp. 9,17 
6 
Table 1. Bioactive annonaceous acetogenins 
ACG name- (MW) Species Organ Mol. THF profile THF References 
Formula Stereo-
chemistry 
Asimicin (622) As. tri/oba, Bark, roots, seeds, pulp. C37Hss07 Adjacent bis- thltlthltlth -~v 
An. comifolia Seeds. 
Bullatacin (a.k.a. As. tri/oba, Bark, pulp. C37Hs607 Adjacent bis- thltlthltler ,10, l~,,,·.a 
rolliniastatin-2) An. bullata, Bark. 
(622) An. comifolia, Seeds. 
R. mucosa Seeds. 
Trilobacin (622) As. triloba Bark C37H6607 Adjacent bis thltler/clth .10 
Bullatalicin (a.k.a. As. triloba Pulp. C37H660S Non-adjacent bis t/th-th/t/er ,~, ,< .~~ • .<4 
cherimolin-1 ) An. cherimolia, Seeds. 
(638) An. bullata Bark. 
Asitrocin (596) As. triloba Seeds C35H6407 Mono erltlth <0 
~ Annonacin (596) As. triloba Bark, seeds. C35Hs407 Mono thltlth IV, '0, ~u-~~ 
An. muricata Pulp, bark, leaves 
An. densicoma Seeds 
Gigantetrocin-A G.giganteus Bark C3sH6407 Mono tlth-th olU 
(596) 
Asitrilobin-C and As. tri/oba Seeds C37H6S07 Mono thltlth ~ 
0(624) 
Squadiolin A (640) An. squamosa Seeds C37H6aOa Mono erltlth ~< 
Diepomuricanin-A An. muricata Seeds C3sH6204 No THFs, rather bis- -- ~~ 
(546) epoxy rings 
Butyrolactone-1 P. macrocarpa Seeds C2sH4203 Linear ACG with no -- ". 
(390) THFs 
Table 1. aNote this is not an exhaustive list; rather this highlights only a few of 
the numerous annonaceous acetogenins with reported bioactivity. See 
references 1, 7 and 8 for thorough reviews of acetogenins and their bioactivities. 
THF stereochemistry refers to the stereochemistry of the bonds between the 
hydroxyl groups and the THF ring(s) and between the THF rings. Abbreviations: 
As. = Asimina, An. = Annona, R. = Rollinia, G. = Goniothalamus, P. = Pha/eria; th 
= threo, t = trans, er = erythro, c = cis. 
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Figure 4. Soursop fruit on tree. 
(http://www.fruitipedia.com/soursop%20 
Annona%20muricata.htm 
Figure 5. Pawpaw fruit on tree. 
(http://www.meridian.k12.iI.us/middle%20school/st 
udent worklrricker native trees/Pawpaw.html) 
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Current research on the acetogenin content of As. tri/oba is focused on 
bis-THFs indicating they are more cytotoxic than mono-THFs and therefore more 
relevant to cancer research 4,8, 11 ,12, 17,35. Annonacin (Figure 6) is a mono-THF . 
acetogenin found in the fruit, twigs, bark and leaves of An. muricata, and it is 
reported to be neurotoxic 10 . 
Figure 6. Structure of Annonacin: C35H6407. 
Though annonacin has also been found in As. tri/oba, these studies focused on 
parts of the plant that provided the most easily accessible extracts, such as twig 
bark or seeds, rather than fruit. 18,27,28, 36 Annonacin has also been detected in 
Paw-Paw Cell Reg™, a natural supplement prepared from As. tri/oba twig 
extracts.8, 26 
Public Health Significance 
As noted above, the annonaceous plants As. tri/oba and An. muricata are 
growing in popularity for various reasons including their potential use in the 
treatment of cancer?' 8 Products from each of these plants are widely available 
online for purchase year-round. The push to increase market awareness of As. 
triloba products as well as the potential medicinal uses for acetogenins is evident 
10 
online and when reviewing the academic literature. 7,8,15-17,26 For example, in a 
recent review of annonaceous acetogenins, Dr. Liaw notes the importance of 
considering these compounds in drug developmene 
In 27 years, more than 500 acetogenins were isolated from 
various parts of the plants of this [AnnonaceaeJ family. These 
bioactive acetogenins became more important, particularly in 
pharmaceutical research. A great interest in investigating the 
mechanisms of action of a series of acetogenins emerged from 
the leaps in knowledge about the processes involved in tumour 
cell death. Members of this class of natural compounds are 
regarded as "potentia/" candidates for future generations of 
anti-cancer drugs. Acetogenins have become one of the most 
interesting classes of natural products at present. 
Such reports highlight the significance of determining the acetogenin 
content of the pawpaw fruit and other plant products. This is especially crucial 
considering reports of neurotoxicity associated with An. muricata, which has 
been traced to the presence of annonacin.10, 37 Specifically, regular consumption 
of fruit and tea from tropical annonaceous plants was reported in two 
epidemiologic studies to be higher in patients with progressive supranuclear 
palsy (PSP) and with an unclassifiable atypical parkinsonian disorder than 
controls in the French West Indies. 38-41 
To date, neurotoxicity studies of the Annonaceae have focused either on 
specific extracts from fruits other than pawpaw (e.g. soursop) or on pure 
annonacin rather than on extracts from As. triloba. 5,6 Recent toxicity studies on 
11 
As. triloba have examined extracts other than annonacin and only considered 
their usefulness as pesticides or cancer-preventing therapies without considering 
potential neurotoxic effects. 3,11.12.42 Again, the focus of these studies has been 
on extracts from those parts of the tree that potentially contain the highest 
concentrations and most easily accessible extracts. The design and/or outcome 
measures of these studies were not appropriate for assessing the risks of chronic 
exposure to extracts or consumption of the fruit. Specifically, potentially 
neurotoxic side effects could not be captured by these studies as safety/toxicity 
was determined based strictly on weight loss or other behavioral changes. 8,42-44 
However, as noted in Dr. Champy's studies, no behavioral abnormalities or 
systemic effects could be detected in rats chronically exposed to annonacin at 
concentrations high enough to produce widespread neurodegeneration.5 Hence, 
the toxicity studies on As. triloba extracts in cancer cells and tumors did not 
consider the possible presence of neuropathology that may have resulted in 
response to their treatment paradigms. Therefore, the acetogenin content of 
pawpaw fruit and elucidation of its neurotoxic potential is an important public 
health issue that should be investigated before pawpaw products become more 
widely used in alternative medicine. 
Relevance to Neurodegeneration 
Though Parkinson's (PO) and Alzheimer's (AD) diseases represent the 
most common neurodegenerative disorders affecting over 1.5 and 5 million 
Americans respectively, there are a number of atypical parkinsonian disorders 
12 
(APDs) that are less common and not as widely researched including 
tauopathies such as progressive supranuclear palsy (PSP), fronto-temporal 
dementia with parkinsonism associated with chromosome 17 (FTDP-17) and 
cortical basal degeneration (CBD). The distribution of degeneration and tau 
pathology varies between tauopathies affecting brainstem and basal ganglia 
nuclei as in PSP and CBD as well as cortical areas as seen in AD, CBD and 
Pick's disease. 45-48 Understanding mechanisms of pathogenesis of these 
diseases may provide useful information that can be translated to their 
representative class of disorders (e.g. tauopathies, parkinsonian disorders) or 
more broadly to the process of neurodegeneration. 
Typical symptoms of PSP include early postural instability and falls, 
vertical supranuclear gaze palsy and L-3,4-dihydroxyphenylalanine (L-DOPA) 
unresponsive parkinsonism, therefore classifying it as an APD.49-51 Additionally, 
while there is loss of dopaminergic neurons in the substantia nigra, similar to PD, 
the pathological hallmarks of PSP, which include the presence of 
hyperphosphorylated tau aggregates depOSited in tufted astrocytes, and 
neurofibrillary tangles (NFTs), more closely resembles AD and categorize it as a 
tauopathy.52,53 Risk factors associated with the development of PSP are 
therefore of interest as elucidation of PSP pathological mechanisms may provide 
insight into the underlying pathologies of both PD and AD. 
An. muricata is reported to be neurotoxic due to its high content of 
acetogenins and tetrahydroisoquinolones (TIQs), which are toxic to nigrostriatal 
neurons by inhibiting mitochondrial complex-1.3, 4, 54-56 This mechanism is similar 
13 
to that following rotenone and 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine 
(MPTP) exposure, which induce parkinsonism in humans and animal models and 
are considered model neurotoxins (see Figure 7 for structures of relevant 
compounds).57-60 MPTP toxicity is due to the production of the toxic metabolite 
1-methyl-4-phenylpyridinium (MPP+), which requires active transport into the cell 
via the dopamine transporter in order to induce mitochondrial inhibition and cell 
death therefore rendering it a dopaminergic specific toxin. 61 Annonacin, the 
major acetogenin of An. muricata, is more potent than MPTP and as effective as 
rotenone at killing nigrostriatal neurons.5, 62, 63 Unlike MPTP, annonacin toxicity is 
not dependent upon the dopamine transporter and its toxicity is not specific to 
dopaminergic cells as it also causes cell death in y-aminobutyric acid 
containing(GABA) and cholinergic neurons.5, 37, 56 To date, studies investigating 
the neurotoxicity of annonacin were tested in cultured striatal or mesencephalic 
neurons 5,6,37,55,63. This is an important distinction considering that cortical and 
other non-dopaminergic neurons are widely affected in tauopathies.45, 46, 52 
Exposure of mesencephalic dopaminergic neurons to the total extract of alkaloids 
from An. muricata root bark and two of its most abundant sub-fractions 
(coreximine and reticuline) resulted in degeneration of 50% of the dopaminergic 
neurons one day later and this toxicity was also not dependent upon the 
dopamine transporter. 55,56 Annonacin is much more potent than these alkaloids 
at killing dopaminergic neurons.6 Furthermore, recent reports suggest that 
pawpaw extracts may be more toxic than extracts from soursop or cherimoya 
(Annona cherimolia ).17 
14 





Figure 7. Structures of some of the complex-1 inhibitors noted throughout the 
text. Coreximine and reticuline are two alkaloids found in An . muricata that have 
been tested for neurotoxicity.55 Annonacin and bullatacin are two acetogenins 
with reported toxicity in various models.37• 42 Rotenone and MPP+ are model 
neurotoxins included for comparison. 
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Annonacin and Tau Pathology 
Located on chromosome 17q21, the tau gene encodes the important 
microtubule associated protein (MAP) tau, which is vital to microtubule dynamics 
including assembly and stability. 64-66 In the human adult there are six different 
tau isoforms expressed as a result of alternative splicing of exons 2, 3 and 10. 
Depending on Exon 10 splicing, tau is expressed with either 3 or 4 repeats (3R or 
4R) of microtubule binding domains (exon 10 inclusion = 4R).67 The ratio of 3R 
to 4R is important in normal neuronal functioning and is disrupted in human 
tauopathies.68,69 Additionally, pathological tau is sufficient for inducing 
neurodegeneration as evident by the association of mutations in chromosome 17 
with fronto-temporal dementia with parkinsonism?O Furthermore, the MAPT H1 
haploptype is associated with increased risk for PSp.67, 71 Therefore, 
understanding the cause and effects of tau pathology is important for elucidating 
the mechanisms of neurodegeneration in diseases with pathological tau 
deposition. 
Annonacin isolated from An. muricata has been reported to cause cell 
death and tau pathology in mesencephalic cultures,37 and neurodegeneration of 
the basal ganglia and brainstem after its chronic, intravenous administration to 
rats 5. Nigrostriatal pathology, mitochondrial impairment and/or tau pathology are 
seen in numerous neurodegenerative disorders including PO, AD and PSP. 45,72, 
73 Accumulation of tau in the cell body is also seen in a number of tauopathies 
including AD and PSp.45, 50, 52, 53, 72, 74, 75 It is reported that, along with cell death, 
low concentration of annonacin results in the migration of the protein tau from the 
16 
axon to the cell body, increased tau protein levels, disruption of microtubules, 
mitochondrial complex-1 inhibition and ATP depletion, which have all been 
shown to occur in the aforementioned diseases.37, 45, 50, 52, 53, 72, 74, 75 These 
studies support the hypothesis that annonacin and other acetogenins in As. 
triloba are neurotoxic and may cause neurodegeneration. 
Model neurotoxins are commonly used in vitro to gain a better 
understanding of the role processes such as mitochondrial impairment, ATP 
depletion, alterations in tau and microtubule disruption play in the development of 
neuropathology?6 Rotenone and MPTP are both model "parkinsonian" 
neurotoxins that have been shown to inhibit mitochondrial complex-1 and induce 
protein aggregation and parkinsonism in vivo (see Table 2 for a brief list of 
neurotoxins).57, 58, 63, 77-81 Eskobar-Khondiker et al. reported that annonacin's 
inhibition of mitochondrial complex-1 is responsible for the redistribution of tau. 
However, they also showed microtubule damage in response to annonacin 
treatment, and prevention of complex-1 inhibition only partially protected 
mesencephalic cultures from annonacin induced cell death?7 It was also 
recently suggested that complex-1 inhibition may not be the primary mechanism 
of neuronal cell death induced by rotenone, which has long been considered a 
classical complex-1 inhibitor. 82 Furthermore, studies have demonstrated that 
neurotoxins may adversely affect microtubule dynamics as a primary mechanism 
of action in addition to inhibiting complex-1.83, 84 
Tau may be phosphorylated at a number of serine and threonine residues, 
some of which are found within the microtubule binding domains with many other 
17 
phosphorylation sites flanking this region (see reference 67 for review of tau 
phosphorylation sites). Tau is hyperphosphorylated in paired helical filaments 
(PHFs) and neurofibrillary tangles (NFTs). Glycogen synthase kinase (GSK)-3j3 
is an intriguing target of study in tau pathogenesis since it is known to 
phosphorylate tau at sites in and around the microtubule binding domain85-87 
GSK-3j3 may playa role in tau pathology as there is increased GSK-3j3 
expression in tau inclusions of tauopathy patients compared to controls.88 
Additionally, rotenone is reported to activate GSK-3j3 and induce tau 
hyperphosphorylation.89 The effect of annonacin on kinase activation has not 
been previously considered and may provide a better understanding of its 
mechanism of action. While GSK-3j3 may playa role in the effects of annonacin 
on complex-1 and consequent changes in tau, annonacin may also directly affect 
it, which in turn may affect the phosphorylation state of tau and/or signal cell 
death independently of complex-1 inhibition. 
Sharing similarities with rotenone and MPTP as well as inducing 
pathological changes in tau makes annonacin a compound of interest for 
neurotoxicity studies.37. 55, 62 Human exposure to MPTP is currently uncommon 
as it is a byproduct in the production of a synthetic narcotic.59 Therefore, while it 
may be a useful tool for mechanistic studies, it does not represent a probable risk 




Table 2. N 
- -- - - -- - -- - -- - - -
f t d 
Toxin Bioactivity Experimental Model Ref. 
ROT LCso =100nmol/L Complex-1 inhibition req'd. SK-N-MC 01 
ROT 2.5mg/kg/day = parkinsomism and widespread NO. Nigrostriatal cell death and tau chronic IV infusion to rats for 28 days ~" 
patholooy. 
ROT 100nM ROT activated GSK313. Toxicity required GSK313 SK-N-MC H~ 
ROT, PQ, Wild type: 10nM ROT= 75% OAergic death and 33% complex-1 inhibition. Wild type and Ndufs4 knockout o. 
MPP+ Complex-1 inhibition not required for toxicity of ROT, MPP or PO midbrain E14 mouse cultures 
Soursop OR for PSP = 20. PSP Symptoms improved after stopping annonaceous human consumption ~o. ~~ 
consumption 
Soursop Gd-PSP and -POC consumed more soursop (150g/life or 2g/kg AN) than controls or human consumption and brain imaging ~u 
PO (25g/life or O.4g/kg) (cummulative) on controls and PO, Gd-PSP and 
GdPOC patients 
Soursop EC50 alkaloid totum=18ug/ml , apoptotic cell death, inhibition OA uptake that was E 16.5 rat mesencephalic culture 00 
(alkaloids) not required for toxicity 
TIQs Decrease in striatal OA ipsi- and contralateral to lesion 7 day unilateral infusion into rat ~ 
striatum 
Complex-1 AN ICso complex-1= 55nM, ECoo ATP depletion= 134nM, ECoodeath= 60nM. MPP+ E 16.5 rat striatal culture O~ 
inhibitors ICso= 2.6mM, ECoo ATP & death = 541JM. ROT ICoo, ECso ATP & death all = 7nM. 
AN AN (3.8 or 7.6mg/kg/day) crosses BBB, inhibits complex-1, decreases ATP, and chronic IV infusion to rats for 28 days ~ 
causes nigro-striatal cell death 
AN LCso = 50nM after 48hrs. ATP depletion, increased tau phosphorylation, somatic E 16.5 rat striatal culture ~( 
redistribution of tau, retrograde transport of mitochondria and MT disruption. 
AN 30nM AN=ICso complex-1, ECoo for TH & MAP2+ cells = 0.0181JM & 0.0271JM AN, E 15.5 rat mesencephalic culture and ~.:>t> 
0.034 & 0.0411JM ROT, 1.9 & 72IJM MPP+ respectively. Brainstem and nigrostriatal IV infusion of AN for 28 days 
lesions and dystrophic fibers. 
For thorough review of complex-1 inhibiting neurotoxins see references 63 and 76. AN = annonacin, ROT = rotenone, 
PO = paraquat, TIO = tetrahydroisoquinolone, SK-N-MC = human neuroblastoma cell line, DA = dopamine, OR = odds 
ratio, IC = inhibitory concentration, EC = effective concentration, MT = microtubule, Gd = Guadeloupian, PDC = 
Parkinson-dementia complex, BBB = blood-brain barrier, TH = tyrosine hydroxylase. 
Rotenone is still approved for use as a pesticide in the United States and 
therefore represents a public health concern; however, though it does induce tau 
aggregation, its toxic effects are not protein specific and therefore its usefulness 
as a model compound translates more generally to neurodegeneration rather 
than a particular disease or set of diseases as is the case with MPTP and PD.37, 
58,76,79 To date, annonacin has been shown to specifically induce tau pathology 
and may therefore represent a novel model neurotoxin that is more etiologically 
relevant to tauopathies than MPTP.37 For these reasons, elucidation of 
annonacin toxicity may provide valuable insight into to the pathogenesis of 
tauopathies including those that present as APDs. 
Research Aims 
Considering that annonacin is present in other (e.g. An. muricata) 
annonaceous fruits and is present in As. triloba bark, it was hypothesized that it 
would also be present in the fruit pulp As. triloba (Le. pawpaw). Additionally, 
while the toxic effects of extracts, including annonacin, from An. muricata have 
been reported in striatal and midbrain cultures, it has not been determined 
whether the extracts or annonacin from As. triloba share this toxicity in cortical 
neurons, which are also affected in a number of the diseases noted above. 
Considering the information discussed above regarding the presence of toxic 
acetogenins in As. triloba and related plants, it was hypothesized that As. triloba 
fruit would contain the neurotoxic acetogenin annonacin and that it would be toxic 
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to cortical neurons. Furthermore, crude acetogenin-containing extract was 
expected to be more toxic than annonacin due to the presence of multiple 
bioactive acetogenins. Finally, it was hypothesized that annonacin would induce 
changes in the tau protein as previously reported. The long-term goal of this 
research is to provide insight into the mechanisms of pathogenesis of 
neurodegenerative diseases to develop better treatment strategies for them. The 
specific aims of this project were as follows: 
AIM I: To determine the presence and concentration of 
annonacin in pawpaw fruit pulp. 
*Is the toxic acetogenin, specifically annonacin, present 
in fruit pulp of Asimina triloba? 
*Is annonacin present in the pawpaw fruit in high enough 
concentration to induce neurotoxicity? 
AIM II: To determine the toxicity of pawpaw fruit extracts in 
primary cortical neurons. 
* Is treatment with annonacin isolated from the pawpaw 
fruit toxic to rat cortical cultures? 
*Is treatment with total acetogenin-containing extracts 
more toxic than pure annonacin? 
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AIM III: To confirm the effect of annonacin on tau 
phosphorylation. 
*Ooes treatment with annonacin isolated from pawpaw 
fruit result in tau hyper phosphorylation or accumulation? 
*Ooes annonacin activate glycogen synthase kinase 
(GSK)-3# as shown in most tauopathies? 
The following chapters detail the methods used to investigate these 
questions and discuss the results in relation to the current literature. 
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CHAPTER II 
MATERIALS AND METHODS 
Extraction and isolation of annonacin from Asimina tri/oba fruit pulp 
Frozen pawpaw pulp was purchased from Integration Acres, Ltd. Fresh 
pawpaws were purchased from A Little Piece of Paradise Farm, Kings Mountain, 
Kentucky. A sample of annonacin isolated from An. muricata was kindly donated 
by Dr. Pierre Champy, Faculte de Pharmacie, Chatenay-Malabry, France, as a 
sample for purposes of comparison with As. tri/oba extracts. Solvents and 
reagents were American Chemical Society (ACS) grade and used as 
commercially supplied (VWR). Analytical thin-layer chromatography (TLC) 
utilized 0.25 mm pre-cut glass-backed plates (Merck, Silica Gel 60 F254). Thin-
layer chromatograms were visualized during chromatographic and extraction 
runs by rapidly dipping the plates in anisaldehyde/ethanol/sulfuric acid stain and 
heating (hot plate). A second technique involved dipping the plates in 3,5-
dintrobenzoic acid/methanol (2%) and heating followed by dipping in 
KOH/methanol (Kedde reagent). The Kedde reagent specifically stains 
acetogenins due to its butenolide reactivity; however, it is far less sensitive than 
anisaldehyde staining, which is not acetogenin specific. Therefore, anisaldehyde 
23 
stain was preferentially used to analyze fractions as they were eluted. Gravity-
column chromatography was carried out using silica gel 60 (E. Merck 9385, 235-
400 mesh) or silica gel 62 (Mallinckrodt 6551,60-200 mesh). Extracts and 
chromatographic fractions were concentrated with a BOchi rotavapor under water 
aspirator vacuum. High Resolution Mass Spectral (HRMS, specifically FTMS 
using ESI) data were measured with a Thermo Electron Corporation L TQ-FT. 
Nuclear magnetic resonance (500 MHz 1H and 13C NMR) spectra were recorded 
with Varian INOVA 500 or VNMRS 400 instruments using deuterated 
dicholormethane (CDC b) as a solvent and internal standard. Infrared spectra 
(Fourier-transform infrared spectroscopy, FTIR) were recorded with a Perkin-
Elmer Spectrum 100 instrument. Optical rotations were recorded with a JASCO 
Dip-370 polarimeter. 
(5S)-5-Methyl-l-[(2R,SR, 1lR)-2,S, 1 l-trihydroxy-1l-[(2R,5R)-5-[(1 R)-1-
hydroxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin 
(AN): Fresh (peeled and seeded fruit) or frozen fruit pulp (1000 g) was 
homogenized in methanol (800 mL) using a commercial blender. The yellow-
green methanolic homogenate was stored overnight under refrigeration. The 
homogenate was then vacuum-filtered with a 150 mm diameter Buchner funnel 
and the filter cake was washed with 50% aqueous methanol in portions (600 mL, 
total) and the application of vacuum was continued after the washing process 
until the sturdy filter cake was slightly damp. The resulting yellow-orange filtrate 
was then poured into a separatory funnel (2000 mL) and extracted with ethyl 
acetate (EtOAc, 3x200 mL) whereupon brine was added as needed to enhance 
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the separation of aqueous methanol and organic EtOAc layers. The crude ethyl 
acetate extracts were combined and the yellow solution was dried over 
anhydrous sodium sulfate (30g) overnight (10°C). The drying agent was 
removed by vacuum filtration directly into a 1000 mL recovery flask while 
washing with fresh ethyl acetate (100 mL). The clear, deep yellow filtrate was 
concentrated by rotary evaporation in vacuo at room temperature (rt). During the 
concentration process, a white precipitate, presumably carbohydrate components 
of the crude extract due to its water solubility, was evident and was removed by 
vacuum filtration while washing with ethyl acetate. The resultant filtrate (crude 
ethyl acetate extract, cEX) was concentrated under vacuum pressure and the 
odorous orange-yellow oil (SOO mg) was kept under refrigeration until submission 
to column chromatography. The concentrated oily cEX was applied to a 2SxSOO 
mm glass column packed with silica gel (2S0mm) and eluted sequentially with 
hexane/ethyl acetate (S:1, SOO mL), hexane/ethyl acetate (2: 1, 200mL), 
hexane/ethyl acetate (1:2, 200 mL), ethyl acetate (100%,100 mL) and ethyl 
acetate/methanol (9S:S, SOO mL). Elution analysis of the individual fractions was 
conducted by TLC with visualization by anisaldehyde stain. The fractions 
bearing annonacin, a less-mobile component and two more mobile components 
were combined and concentrated under vacuum. The combined oily, 
chromatographed concentrate was submitted to a second column 
chromatography using the same volume of silica gel and eluted with hexane/ethyl 
acetate (1 :1,200 mL), hexane/ethyl acetate (1 :2,300 mL) and ethyl 
acetate/methanol (9S:S, 300 mL) again testing each fraction by TLC. The 
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occurrence of a persistent higher-running component necessitated a third 
chromatographic run using the same conditions as the second. Final annonacin 
and acetogenin containing fractions were identified by TLC visualized with 
anisaldehyde and Kedde staining and weight determined following solvent 
removal in vacuo. FTMS and NMR were used to compare the isolated 
annonacin to an annonacin sample from An. muricata and synthetic annonacin 
data.90 
(5S)-5-Methyl-3-[(2R,SR, 13R)-2,S, 13-triacetoxy-13-[(2R,5R)-5-[(1 R)-1-
acetoxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin 
tetra acetate (AN-Ac): Crude annonacin (79 mg, 0.13 mmol) was dissolved in 
pyridine (200 jJL, 2.5 mmol) and then acetic anhydride (100 jJL, 1.0 mmol) was 
added by syringe. The reaction mixture was stirred (48h, rt) whereupon TLC 
(hexanes/ethyl acetate, 2:1) indicated complete consumption of starting material 
and formation of a higher-running spot. The reactants were removed under high 
vacuum and the viscous residue was dissolved in dichloromethane and applied 
to a gravity silica gel column. Elution of the column with hexanes/ethyl acetate, 
2: 1 followed by combination and concentration of the fractions yielded the 
annonacin tetraacetate derivative. The spectral data was compared to that of 
isolated annonacin. Optical rotations and infrared spectra (FTIR) were also 
recorded for samples of annonacin and annonacin tetraacetate. 
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In vitro toxicity of annonacin and Asimina triloba organic fruit extract 
and effects on microtubule associated protein tau 
Known amounts of purified annonacin and cEX were dissolved in dimethyl 
sulfoxide (DMSO) or ethyl acetate (EtOAc) to make 50 mM and 75mg/ mL stock 
solutions respectively, which were stored at -80°C. Acetogenin-free fractions 
(ACG-free) isolated from cEX alongside annonacin were diluted in DMSO to 22 
mgt mL and stored at -80°C. Stock solutions of 1 mM rotenone (Sigma R8875) 
were prepared in DMSO or EtOAc prior to each experiment. Serial dilutions of 
drugs were prepared in basal medium Eagle (BME, Sigma) immediately before 
each experiment. Reagents used for neuronal cultures and analytical techniques 
were used as commercially supplied or prepared fresh according to manufacturer 
protocols and pH adjusted to 7.4 with sodium hydroxide. 
Cell Cultures. Cortical neurons were cultured from newborn Sprague-
Dawley rat pups on postnatal day 0 (PO) according to previously published 
methods.91 The handling of animals followed Institutional Animal Care and Use 
Committee approved procedures. For viability assays, cultured neurons were 
plated in 96-well culture plates coated with poly-D-Iysine (POL, 5%) at a density 
of 4.8-6.4 x 104 cells/ well. For immunocytochemistry, cells were plated at a 
density of 0.5 x 106 cells/ well in 24-well plates with POL and laminin coated 
glass coverslips. For western blotting, cells were plated in 35 or 60 mm culture 
dishes coated with POL at densities of 2.0 or 4.0 x 106 cells/ well respectively. 1-
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(~-D-Arabinofuranosyl) cytosine (Ara-C, 2.S I-lM) was added to all wells on day 2 
in vitro (DIV 2) to inhibit proliferation of non-neuronal cells. 
Cells were treated with annonacin, cEX, ACG-free extract, rotenone or 
vehicle (DMSO or EtOAc) on DIV S. The amount of DMSO in control cultures did 
not exceed O.S% unless otherwise noted. The toxicity of EtOAc, as well as 
MeOH and ethanol (EtOH), was tested against the typical vehicle control, DMSO, 
prior to performing experimental treatments with EtOAc. ACG-free extract 
served as a negative control for the extraction process. These fractions were 
considered to be ACG free due to the fact that they lacked Kedde positive 
staining when heavily spotted on TLC. In addition to being Kedde negative, 
these fractions were chosen as negative controls because they eluted closely 
with the annonacin containing fractions therefore representing the most similarly 
processed extracts. 
Rotenone toxicity in cortical and midbrain neurons varies depending on 
the experimental paradigm, with reported toxicity ranging from low nanomolar to 
micromolar concentrations.63. 77. 92-97 Considering these varying reports, and that 
high concentrations of rotenone may induce cell death via different 
mechanisms,96 1 flM rotenone was used as a positive control for neurotoxicity. 
Viability Assay. MTT (3-(4,S-dimethylthiazol-2-yl)-2,S-
diphenyltetrazolium bromide) is converted to a formazan product by 
mitochondrial dehydrogenase in live cells. As the rate of conversion is 
proportional to the number of surviving cells, it provides a convenient measure of 
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cell viability.98, 99 Therefore, the MIT assay was used as previously described to 
assess the toxicity of each treatment relativeto vehicle-treated controls. 1oo Forty-
eight hours post-treatment MTT was added to 96-well plates and incubated for 2 
hours followed by overnight solubilization in 1:1 N,N-dimethylformamide and 
sodium dodecyl sulfate (SDS, 20% in di-H20). Absorbance was determined at 
570nm with a Spectra Max spectrophotometer and analyzed with Soft-max pro. 
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde at 0, 
8, 24, and 48 hours and immunostained following standard procedures91 with 
rabbit anti-MAP2 (microtubule associated protein 2) polyclonal antibody (Cell 
Signaling Technologies #4542, 1 :200), mouse anti-total tau (DA9, 1 :500), anti-tau 
phosphorylated at serines 396 and 404 (PHF-1, 1 :500), anti-tau phosphorylated 
at serine 202 (CP-13, 1 :500) or anti-tau conformational epitope MC-1 (recognizes 
amino acids 7-9 and 326-333, 1 :100) monoclonal antibodies (all tau antibodies 
were kindly provided by Dr. Peter Davies, Albert Einstein College of Medicine). 
IGg, secondary antibodies used included goat anti-mouse Texas Red 
(Calbiochem #401218), AlexaFluor #488 goat anti-mouse or goat anti-rabbit 
(Invitrogen #A 11029 and A 11034, respectively). Nuclear chromatin was co-
stained with Hoechst 33258 (Sigma). Images were captured on a Zeiss 
AxioObserver A.1 inverted light microscope with a Zeiss AxioCam MRM canon 
camera using AxioVision 4 software. 
Western Blot Analysis. At 1, 4, 8, and 24 hours after treatment, cells 
were lysed with SDS lysis buffer and stored at -20°C. Equal amounts of cell 
Iysates were run on 10% acrylamide gels according to standard laboratory 
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procedures.91 , 101 The tau antibodies noted above were used to probe for total 
and phospho-tau epitopes. Anti-GSK-3~ total (cell signaling #9332, rabbit 
1:1000) and -phospho-serine 9 (Biosource #44-600G, rabbit 1:1000) were used 
to probe for total and inactive GSK-3~. Anti-~-actin (Sigma #A5316, mouse 
1 :2000) was used as a loading control for each probe. Secondary horseradish 
peroxidase conjugated mouse and rabbit antibodies were used according to 
manufacturer's protocol (CalBiochem #402335 and #401315, respectively, 
1: 1 0,000). Protein expression was quantified by iIIuminescence on a Kodak 
Image Station 4000R using GE software and normalized to loading controls. 
Statistical Analysis. Absorbance of treated cells was normalized to 
controls for each 96-well plate. The raw values normalized to vehicle-treated 
controls were used to determine relative viability of treated cells. Annonacin 
toxicity was determined from a total of 13 independent experiments (22 total 96-
well plates). cEX and ACG-free treatments were tested in a total of 3 
independent experiments (3 and 5 total 96-well plates respectively). In some 
instances multiple 96-well plates were used as replicates within that experiment, 
hence the above indication of the total number of plates. On each 96-well plate, 
6 replicate wells (or sister cultures) were used per treatment. Rotenone was 
included as a positive control on each plate. The mean, 95% confidence 
intervals, and p-values were determined for each treatment using Graph-Pad 
prism software. One-way analysis of variance (AN OVA) followed by Dunnette's 
post-hoc test was used to determine significance, and non-linear regression 
analysis to calculate the LDso of annonacin. 
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Lysates from a total of 4 independent experiments were analyzed via 
Western blot. Background was subtracted from each lane and all lanes 
normalized to their corresponding loading control (Beta actin). Relative 
phosphorylation was determined by also normalizing each phospho-epitope to its 
respective total antibody expression. For example, after being normalized to 
loading control, GSK-3J3 phospho-serine 9 values were also normalized to total 
GSK-3J3. All treatment wells were normalized to controls and one-way ANOVA 
with Dunnette's post-hoc test was used to determine differences in protein 
expression between control and annonacin treated cells. P-values < 0.05 were 




Extraction and isolation of annonacin from Asimina triloba fruit pulp 
Extraction and Isolation. TLC, FTMS, 1H_ and 13C-NMR, FTIR 
spectroscopic analyses and polarimetry (optical rotation) revealed the presence 
of annonacin in extracts isolated from pawpaw fruit pulp. When examined by 
TLC in multiple solvent systems, isolated annonacin co-spotted with the An. 
muricata sample (Figure 8). FTMS and NMR spectra corresponded with that of 
the annonacin sample (Figures 9-10), and NMR shifts were consistent with 
those previously reported for synthetic annonacin90 (Table 3). 
(5S)-5-Methyl-3-[(2R,8R, 13R)-2,8, 13-trihydroxy-13-[(2R,5R)-5-[(1 R)-1-
hydroxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin: 
R,= 0.35. HRMS calculated for C3sH6407 m/z [m + Nat: 619.4543; Found: 
619.4546 ± 0.6 ppm. 1H NMR 0 (400MHz, CDCb): 7.18 (s, 1H), 5.06 (q, 
J=6.8Hz, 1H), 3.85 (m, 1H), 3.81 (dt, J=6.8Hz, 12Hz, 2H), 3.59 (m, 1H), 3.41 (dt, 
J=6.8Hz, 12Hz, 2H), 2.52 (d, J=14Hz, 1H), 2.40 (dd, J=15.2Hz, 8Hz, 1H), 2.06 
(m, 4 OH), 1.98 (m, 2H), 1.65 (m, 2H), 1.62-1.25 (m, 40H), 1.43 (d, J=6.8Hz), 
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0.88 (t, J=6.8Hz, 3H); 13C NMR (400MHz, CDCI3) <5: 174.51, 151.85, 131.14, 
82.66,82.58,77.98,74.08,73.97,71.72,69.88, 37.32, 37.25, 33.42, 33.35, 
31.90,29.70,29.65-29.62 signal overlap, 29.44, 29.33, 28.74, 25.63,25.57, 
25.47,22.66,19.08,14.09. FTIR 3416,2922,2852,1744,1075 cm-1. [a]020: 
+20.4° (c=0.51, CHCb). 
Isolation Optimization. The extraction and isolation process described 
here represents a high-yield, reliable method for both preparing and purifying 
extracts of the acetogenins from frozen fruit pulp and isolating annonacin. The 
aforementioned procedure yielded pure annonacin (-90%) as determined by 
HRMS (FTMS), high-field NMR, FTIR and optical rotation. The fruit of the 
Eastern pawpaw tree, As. tri/oba is commercially available from health food 
stores or local farms (See Materials and Methods). A kilogram of the raw peeled 
fruit or commercially available frozen pulp may be conveniently processed on a 
laboratory scale using a blender. Although extracting freeze-dried pulp with 
organic solvents was considered for the initial stages of the process, the solvent-
solvent extraction of filtered homogenate derived from fresh or frozen pulp was 
the best expedient in terms of time and mass transfer. Although classed as a 
lipid, annonacin possesses four hydroxyl groups and is relatively polar as 
compared to many other classes of small-molecule lipids. When choosing 
solvents for the extraction-partitioning steps, methanol and ethyl acetate, 
respectively, were found to be optimal and the sequence repeatedly delivered 
-500 mg of crude extract per kilogram of pulp. On initial concentration of the 
crude syrupy extract, a granular white water-soluble/ethyl acetate insoluble 
33 
precipitate was observed, which was presumably the carbohydrate portion of the 
extract and easily removed by vacuum filtration. At first a portion of the crude 
isolate was submitted to flash chromatography (F-C) 102 on silica gel using 
combinations of chloroform-methanol, since the chloroform methanol system was 
optimal for separation of the suspected acetogenin components on analytical 
TLC. However, the F-C system was not optimal since many of the less-polar 
compounds, presumably terpenes or terpene-like compounds were carried 
through before separation was effected. The most effective separation system 
was a gravity silica gel column which utilized combinations of hexanes/ethyl 
acetate and ethyl acetate/methanol with gradually increasing polarity of the 
solvent mixtures. While previous work on natural products bearing the butenolide 
(a,~ -unsaturated-Y-Iactone) subunit utilized the two-step Kedde reagent for 
detection during chromatography, 103 the o-anisaldehyde TLC stain for the 
individual fractions was the best expedient. While the Kedde reagent system 
confirmed the presence of the desired acetogenin, the o-anisaldehyde TLC stain 
was superior in terms of time and sensitivity for routine separations. Separation 
and 1 H NMR (500MHz) analysis of the intermediate fractions eluted with the ethyl 
acetate/methanol solvent sequence revealed the presence of annonacin on 
comparison with spectral data published by Wu and co-workers through their 












































Figure 8. TLC of annonacin isolated from Asimina triloba co-spotted with an 
annonacin sample from Annona muricata. TLC mobile phase: 
chloroform/methanol (9: 1), stained with anisaldehyde and Kedde reagent. R,= 
0.35. ANsMP = annonacin sample derived from An. muricata, ANpp-EX = pure 
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Figure 9. Fourier transform mass spectrometry (FTMS) spectra of crude ethyl 
acetate extracts of As. tri/oba fruit pulp (cEX) reveals presence of annonacin 
among other acetogenins (A). Spectra of annonacin-containing fractions after 
the second (8) and third (C) chromatographic runs. Spectra of annonacin 
sample derived from An. muricata (0). Comparison of As. triloba isolated 
annonacin (E) with the An. muricata sample (F) showing a more narrow range of 
spectra surrounding the annonacin peaks from C and o. High Resolution Mass 
Spectrometry (HRMS) calculated for annonacin, C3sH6407mlz [m + Nat 
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Figure 10. Proton nuclear magnetic resonance CH NMR) spectra of annonacin from As. triloba fruit pulp (A) and 
An. muricata (8). Spectra obtained with VNMRS 400MHz instrument using CDCb as solvent and internal standard. 
Table 3. Chemical structures and 1H and 13C NMR Data for Annonacin (R=H) 
and Annonacin Tetraacetate (R=Ac) 
OR 
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32 11 10 9 
R=H, 1H assignment R=H, l :iC assignment R=Ac. 'H assignment 
C-l : 174.7 
C-2: 131 .2 
H-3a: dd, 2.40 (15.2, 8.0) C-3: 33.3 
H-3b: dd, 2.52 (15.2, 8.0) 
H-4: m, 3.85 
H-5-H-9: m, 1.25-1 .62 
H-l0: m, 3.59 
H-ll-H-14: m, 1.25-1 .62 
H-15: dt, 3.41 (12.0, 6.8) 
H-16: m, 3.81 
H-17: m, 1.65/ m, 1.98 
H-18: m, 1.65/ m, 1.98 
H-19: m, 3.81 
H-20: dt, 3.41 (12.0, 6.8) 
H-21-H-31 : m, 1.25-1 .62 
H-32: t, 0.88 (6.8) 
H-33: d, 7.18 (1 .4) 
H-34: qd, 5.06 (6.8, 1.4) 













C-33: 151 .9 
C-34: 78.0 
C-35: 19.1 
H-3a: dd, 2.52 (14.4, 4.0) 
H-3b: dd, 2.52 (14.4, 4.0) 
H-4: m, 4 .80-5.02 
H-5-H-9: m, 1.25-1 .40 
H-l0: m, 4.80-5.02 
H-l1-H-14: m, 1.25-1 .40 
H-15: m, 4.80-5.02 
H-16: m, 3.97 
H-17: m, l .73/m, 1.94 
H-1 8: m, l .73/m, 1.94 
H-19: m, 3.97 
H-20: m, 4.80-5.02 
H-21-H-31 : m, 1.25-1.40 
H-32: t, 0.88 (7.0) 
H-33: d, 7.09 (1 .5) 
H-34: qd, 5.09 (7.0,1.5) 
H-35: d, 1.40 (7.0) 
CH3 (Ac): 5 , 2.03; 5, 2.04; 5, 2.07 
.-" 35 
13 R=Ac, C assignment 
C-l : 173.4 
C-2: 130.1 
C-3: 30.8 










C-21-C-31 : 22.6-34.0 
C-32: 14.1 
C-33: 151 .9 
C-34: 77.5 
C-35: 18.9 
C=O (Ac): 170.6; 170.8; 170.9 
CH3 (Ac): 21 .1-21 .2 
Isolated and purified materials were dried and dissolved in CDCb (chemical shifts 
o in ppm; coupling constants J in Hz; 100 and 400 MHz), Arrows highlight 
positions where assignments differ between isolated and acetylated annonacin, 
confirming the presence of reactive hydroxyl groups_ 
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Annonacin tetraacetate. The derivatization of polyol natural products by 
conversion to the less polar acetate or even benzoate ester is a common practice 
which facilitates smooth chromatographic purification of the parent compound or 
may provide additional data for its thorough characterization.104, 105 106 Crude 
annonacin was treated with acetic anhydride and pyridine (4Bh/rt) producing the 
chromatographically more mobile and solvent-soluble annonacin tetra acetate 
(Figure 11) after purification by silica gel column chromatography (40.2 mg, 
40%). TLC revealed complete consumption of the starting material (Figure 12) 
and increased silica gel mobility. The tetra acetate was characterized and 
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Figure 11. Conversion of annonacin to the tetraacetate derivative. 
Annonacin and tetraacetate TLC 
Anisaldehyde 
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Figure 12. TLC of annonacin co-spotted with the annonacin tetra acetate 
derivative shows complete consumption of starting material and evidence of 
increased mobility on silica gel of the tetraacetate. TLC mobile phase: 
chloroform/methanol (9: 1) and hexane/ethyl acetate (1: 1), stained with 




acetoxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one. Annonacin 
tetraacetate: R,= 0.40. HRMS calculated for C43H72011 m/z [m + Nat: 
787.4966. Found: 787.4963. 1H NMR (500 MHz, COCh) d: 7.09 (s, 1H), 5.10 
(m, 1H), 5.01 (J=7Hz, 13.5Hz), 4.85 (m, 3H), 3.97 (m, 2H), 2.55 (q, J=4Hz, 
14Hz), 2.52 (q, J=4Hz, 14Hz), 2.07 (s, 6H) signal overlap, 2.04 (s, 3H), 2.03 (s, 
3H), 1.94 (m, 2H), 1.5-1.59 (m, 12H), 1.40 (d, J=6.5Hz), 1.25-1.4 (m, 30H), 0.88 
(t, J=7Hz, 3H). 13C NMR (100 MHz, COCI3) 0: 173.44, 170.87, 170.85, 170.59, 
150.90,130.14,79.54,79.43,77.50,74.92,74.73, 74.00, 71.84, 34.01, 33.99, 
31.87,30.82.30.75.29.84,29.62,29.65-29.59 signal overlap, 29.52, 29.44, 
29.30,29.20,28.03,28.02,25.29,22.64,21.22, 21.10, 21.08, 18.89, 14.07. 
[a]020 +7.45° (c=0.51 ,CHCh). FTIR 2927,2856, 1744, 1737, 1241 cm-1. 
The successful formation of annonacin tetraacetate provided additional 
confirmation that our isolated material was annonacin as noted by shifts in 
FTMS, NMR and FTIR absorptions where expected (Figures 13-15). Arrows in 
Table 3 highlight where chemical shifts differ between annonacin and the 
tetraacetate. These shifts confirm the conversion of hydroxyl groups to acetates, 
as expected. Specifically the loss of OH bending in the FTIR tetraacetate 
spectra indicated disappearance of the 4 hydroxyl groups that were evidenced by 
a broad absorption band at 3416.74cm-1 in the annonacin spectra. Furthermore, 
the optical rotation ([a]020 = +20.4°) of our purified material corresponds to that of 
annonacin prepared by stereoselective synthesis ([a]020 = +21),107 which confirms 
that it possesses the same stereochemistry as annonacin. 
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FTMS of annonacin and annonacin-tetraacetate 
A LP 154_3_AC FT MS #1 RT: 0.02 AV: 1 /l.L. 0<.",,'=8 
T: FTMS + p ESI Full ms [50.00-1000.00) 
B 
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Figure 13. FTMS spectra for tetraacetate derivative of isolated annonacin (A). 
Panel B shows a more narrow range of the spectra around the tetraacetate peak. 
HRMS calculated for annonacin tetraacetate, C43H7201 1m/z [m + Nat 787.4966; 
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Figure 14. Comparing 1H NMR spectra for annonacin (A) and annonacin 
tetra acetate (8) shows shift in peaks where expected. Spectra obtained with 
VNMRS 400MHz instrument using CDCb as solvent and internal standard. 
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Figure 15. Fourier transform infrared (FTIR) spectra of annonacin isolated from 
Asimina triloba: 3416.74cm-1 = OH groups, 2922.2cm-1 = CH2's, 2852.19 cm-1 = 
THF ring, 1744.09cm-1 = butenolide (A) compared to spectra of the tetraacetate 
derivative 2927.53 cm-1 = CH2'S, 2856.29 cm-1= THF ring, 1737.72 cm-1 = 
acetates with butenolide shoulder (8). Note, as expected, in 8 there is no longer 
a peak corresponding to the OH groups confirming complete consumption of 
starting material and tetraacetate formation. Purified samples dissolved in CHCb 
and spotted on salt plates for spectral acquisition using Perkin-Elmer Spectrum 
100 instrument. 
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Quantification. The amount of annonacin isolated per gram of frozen 
fruit pulp was 0.07 ± 0.03 mg as determined by average weight from extractions 
on 5 separate batches (Table 4). Based on repeated extractions it was 
determined that annonacin represents 0.01 % of pawpaw pulp by weight 
determination. On average, annonacin made up ten percent of the total crude 
EtOAc extract (cEX). One additional extraction was done on locally harvested 
fresh fruit, which gave an annonacin yield of 0.12 mg per gram of pulp. 
Table 4. Annonacin content of Asimina triloba vs. Annona muricata 
Average Amount Amount 
total fruit annonacin annonacin per 
weight1 (g) per fruit gram of fruit 
(mo) pulp2 (mo/o) 
Asimina triloba -300 
Frozen fruit 7.0 0.07 
pulp 
Fresh fruit pulp3 12.3 0.12 
Annona -800 15.0 0.02 
muricata 
1Note these values reflect weight of the whole fruit (Le. including 
skin, seeds and pulp). 2The amount of annonacin per gram of fruit 
pulp is based on the amount of pulp used in the extraction, not the 
weight of the whole fruit. 1o 3Quantities in fresh fruit are based on 
data from one extraction; one pawpaw fruit yielded 100 grams of 
pulp on average. 
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In vitro toxicity of annonacin and Asimina triloba organic fruit extract 
Annonacin treatment reduced the number of viable cells remaining in the 
culture 48 hours after treatment at concentrations as low as 10 ~M (p < 0.001, 
Figure 16) as determined by MTT assay. Immunocytochemistry confirmed 
neuronal toxicity as shown by a decrease in MAP2 immunoreactivity and 
changes in neuronal morphology indicative of neurodegeneration, prior to cell 
death (Figure 17). Similar to MAP2 staining, images reveal an overall decrease 
in total tau (DA9) immunoreactivity in response to annonacin treatment (Figure 
18) confirming annonacin toxicity in neuronal cells. 
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~ pure [AN] 
• rotenone 
Figure 16. MTT assay of cortical neurons 48 hours after treatment with purified 
annonacin isolated from Asimina triloba fruit pulp. LD50 for annonacin = 50.45 
IJM (i.e. ) ± 1.07. Bars represent mean (± SEM) viability relative to vehicle 
control-treated cultures. Diagonal lines = annonacin (IJM). checkered fill = 
rotenone (IJM), p-value < 0.001 (***). 
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Time-response of MAP2 immunoreactivity in cortical neurons after annonacin treatment 
vc AN ROT 
8h 
~ 24 h 
48 h 
Figure 17. Cells were fixed as noted in the text at 8,24, and 48 hours after 
treatment and visualized with anti-MAP2 immunotstaining (red). Nuclear 
chromatin was co-stained with Hoechst (blue). Merged images are shown. VC = 
vehicle (DMSO) control; AN = 75IJM annonacin; ROT = 1 IJM rotenone. A 
decrease in MAP2 immunoreactivity in response to annonacin treatment confirms 
neuronal toxicity. All images taken with 20x objective; scale bar = 100 IJm. 
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Tau immunoreactivity in cortical neurons after annonacin treatment 
Hoechst DA9Tau Merge 
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Figure 18. Cells were fixed as noted in the text at 8 and 24 hours after treatment 
with either 75 ~M annonacin (AN) or 1 ~M rotenone (ROT). Immunostaining with 
anti-total tau antibody OA9 (green) suggests an overall reduction in tau in 
response to annonacin treatment. Nuclear chromatin was co-stained with 
Hoechst (blue). VC = vehicle (OMSO) control. All images taken with 20x 
objective; scale bar = 50 ~m. 
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During initial treatments with cEX, an oily precipitate was noticeable in the 
culture media, indicating that cEX was not completely dissolving and therefore 
likely not reaching the cells to have an effect. Therefore, experiments were 
conducted to determine the most appropriate solvent for cEX that would also be 
tolerated by the cultured neurons. Data showed that EtOAc was well tolerated by 
the cells (Figure 19). As expected considering the extract procurement process, 
EtOAc was also the most effective of the solvents considered (DMSO, MeOH, 
EtOH, EtOAc) at dissolving cEX. ACG-free treatment did not result in cell death 
indicating that the processing of extract components per se is not sufficient for 
procuring toxic material (Figure 20). The LD50 values for purified annonacin and 
cEX 48 hours after treatment were 30.07 ~g/ml (Le. 50.45 ~M) and (47.96 ~g/ml) 
respectively, as determined by non-linear regression analysis of MTT viability 
data. Comparison of LD50 values between pure annonacin and the amount of 
annonacin present in cEX (LD50 = 4.80 ~g/ml) confirmed that cEX has more toxic 
potential than annonacin by itself (p < 0.0001, Figure 21). Though the lack of 
significant difference between pure annonacin and total cEX suggest that the 
presence of other compounds in cEX may affect annonacin toxicity. 
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Figure 19. Relative viability of primary cortical neurons 48 hours after treatment with one of 
three solvents (MeOH, EtOH, and EtOAc) as determined by MTT assay. Values for each 
solvent were normalized to the standard DMSO control. EtOAc consistently resulted in high 
levels of viability compared to DMSO treated controls. Due to the dramatic difference in relative 
viabilities between solvent groups, MeOH and EtOH relative viabilities are plotted on left Y-axis 
whereas EtOAc relative viability is plotted on right Y-axis. X-axis is the amount of solvent added 
(Le. 0.5-2.5 IJI) per well on a 96-well plate (total volume = 200 IJI' well). Rotenone treatments 
were included as positive controls for achieving toxicity in each solvent. ROTs = 1 IJM rotenone 
added in respective solvent but normalized to DMSO control. ROTsn = 1 IJM rotenone added in 
respective solvent and normalized to respective solvent. 1IJM ROT = 1 IJM rotenone added in 
DMSO and normalized to DMSO. Bars represent average of wells from one (MeOH and EtOH) 
or three (EtOAc) independent experiments. Error bars = SEM. Numbers above columns are 
the actual values of relative viability for the respective treatment. 
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Figure 20. Relative viability of cEX (crude, red bars) was significantly lower at 
each dose than ACG-free (plaid bars) treatment p < 0.0001 (****). All doses of 
cEX significantly reduced cell viability compared to vehicle-treated controls (p < 
0.001). ACG-free treatment only significantly reduced viability at high 
concentrations (Le. ~ 500 !-Ig/ml, p < 0.01). Bars represent relative viability, 
normalized to controls (mean ± SEM). P-values determined by one-way ANOVA 
with Dunnett's post hoc comparison. 
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Dose-responses of cortical neurons 48hrs after 
pawpaw extract treatments 
-1 o 1 2 3 
Log(Dose) Jl9/ml 
Figure 21. Dose-response curves for cEX (crude, red line, LD50 = 47.96 jJg/ml) 
and for pure annonacin (jJg/ml) (solid blue line) compared to amount of 
annonacin (jJg/ml) in the crude extracts (dashed blue line) 48 hours post-
treatment. LD50 of pure annonacin alone (30.07 jJg/ml , i.e. 50.45 jJM ) is 
significantly higher than that of annonacin in the presence of crude extracts (4.80 
!-Ig/ml , p < 0.0001 (****)) . LD50 values determined by nonlinear regression of 
log (dose) v. relative viability. Gray dashed lines represent 95% confidence 
intervals for dose-response data. 
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In vitro effects of annonacin on microtubule associated protein tau 
Considering the changes in neuronal morphology noted above by MAP2 
and tau staining, the effect of annonacin on tau in cortical neurons was assessed 
at early time-points. To further assess annonacin's effect on tau, Western 
blotting was utilized to determine changes in the levels of tau expression 4 hours 
after treatment (Figure 22). Contrary to previous reports,37 but consistent with 
the above noted patterns of tau-immunostaining, annonacin resulted in a 
decrease in total tau (DA9, p < 0.01). Statistical analysis of western blot data 
revealed that neither annonacin nor rotenone resulted in any changes in tau 
phosphorylation. Originally it was hypothesized that annonacin would induce tau 
phosphorylation. Since GSK-3J3 is known to phosphorylate tau, it was also 
hypothesized that annonacin treatment would activate GSK-3J3, therefore 
western blot analysis of total GSK-3J3 and GSK-3J3 phosphorylated at serine 9 
(inactive form) was performed. In contrast to the initial hypothesis but consistent 
with the above noted changes in tau, annonacin did not induce any changes in 
GSK-3J3 expression (Figure 23). 
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Tau expression 4 hrs. after annonacin treatment 
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Figure 22. Western blot analysis of tau protein expression was performed as 
described in the text. J3-actin was used as loading control. Lysates from 4 
different experiments were run on the same blot (A) with letters A-D representing 
a different experiment. In A, lanes 1-5 are VC, VC, AN, AN, R. In B lanes 1-3 
are VC, AN, R. In C, lanes1-3 are VC, VC, AN. In 0, lanes 1-2 are VC, AN. VC 
= vehicle (DMSO) control, AN = 75 IJM annonacin, ROT = 1 IJM rotenone. 
Quantitative analysis of relative abundance is graphically represented in panel B. 
One-way analysis of variance (ANOVA) with Dunnett's post-hoc test revealed a 
significant decrease in the amount of total tau (DA9, p-value = 0.01 (*)) 4 hours 
after annonacin treatment. Bars represent relative expression from 4 
independent experiments (mean ± SEM) as determined by normalizing 
absorbance values for each blot to its respective beta-actin blot and then to 
vehicle control. Phospho-tau epitopes were also normalized to total tau in order 
to determine relative phosphorylation. Diagonal lines = DA 9, small checks = 
PHF-1, diamond = MC-1, horizontal lines = CP-13. 
68 

















Figure 23. Western blot analysis of GSK-3J3 expression was performed as 
described in the text. J3-actin was used as loading control. Lysates from 4 
different experiments were run on the same blot (A) with letters A-D representing 
a different experiment. In A, lanes 1-5 are ve, ve, AN, AN, R. In B lanes 1-3 
are ve, AN, R. In e, lanes1-3 are ve, ve, AN. In 0, lanes 1-2 are ve, AN. ve 
= vehicle (DMSO) control, AN = 75 j..IM annonacin, ROT = 1 j..IM rotenone. 
Quantitative analysis of relative abundance is graphically represented in panel B. 
One-way analysis of variance (ANOVA) with Dunnett's post-hoc test revealed no 
significant changes in GSK-3J3 expression 4 hours after annonacin treatment. 
Bars represent relative expression from 4 independent experiments (mean ± 
SEM) as determined by normalizing absorbance values for each blot to its 
respective beta-actin blot and then to vehicle control. Phosphorylation of GSK-




Extraction and isolation of annonacin from Asimina tri/oba fruit pulp 
The above results have (1) revealed the presence of annonacin in fruit 
pulp of the annonaceous tree, Asimina triloba, and (2) determined the amount of 
annonacin per gram of pulp. The presence of annonacin in fresh and frozen 
pawpaw fruit was verified by chromatographic and spectroscopic techniques. 
The extraction, isolation and chromatographic purification of annonacin from 
pawpaw fruit described herein is an effective method for procuring the material in 
suitable enough quantities so that both biological and chemical studies may be 
conducted. The fresh or frozen fruit is readily available in large quantities and 
the maceration/liquid-liquid partitioning protocol is time-effective and precludes 
the use and expense of freeze-drying equipment. Based on repeated extractions 
it was determined that annonacin represents 0.01 % of pawpaw pulp by weight 
determination. This is higher in comparison to other sources of annonacin: 
0.0004% Annona cherimolia seeds107 and 0.002% Annona muricata (soursop) 
pulp;1o presenting pawpaw fruit pulp as a new, easily accessible source of 
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biomass for isolating substantial amounts of annonacin for use in biological 
studies. 
The first stereoselective synthesis of annonacin involved multiple (24+) 
steps and yielded similar quantities of annonacin.9o A shorter synthetic route to 
annonacin was recently reported; 108 however, this technique still involved 
multiple steps (14+) and may not be optimal for obtaining large quantities. 
Therefore, the isolation technique reported here proved to be more efficient than 
original synthetic strategies for procuring annonacin in quantities suitable for 
small scale biological studies. Nevertheless, while natural product isolation is 
useful for small scale studies, development of a novel synthetic strategy with 
minimal steps is necessary to routinely procure quantities large enough to 
maintain multiple, ongoing biological studies. 
The high concentration of annonacin in pawpaw pulp reported here is 
significant considering the neurotoxicity reported by Champy and colleagues in 
annonacin treated rats,5 which suggest that regular consumption of the 
annonaceous fruit, soursop, could lead to neurodegeneration. Specifically, Dr. 
Champy's results indicate that the amount of annonacin present in one soursop 
fruit is high enough such that regular consumption (i.e. one fruit per day per year) 
could lead to neurodegeneration.1o This is consistent with epidemiological 
reports of increased overall lifetime consumption of annonaceous products in 
atypical parkinsonian cases (2g/kg) compared to controls (O.5g/kg).40 Therefore, 
one would need to consume on average approximately 1 soursop fruit per day for 
25.6 years to reach the aforementioned overall level of consumption. This same 
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level of annonacin intake could be reached in 27.3 years by consuming an 
average of approximately 10 pawpaw fruits per day for 90 days per year 
(according to annual availability of ripe fruit). Though this is substantially more 
fruit to consume in one day, it is plausible considering the relatively small size of 
each pawpaw compared to soursop (100 versus 750 g of pulp, respectively). 
Fresh pawpaw is less likely to be consumed year-round, hence the difference in 
the number of days consumed per year between the 2 fruits. However, due to 
the increasing popularity of pawpaw, fruit products (e.g. frozen fruit pulp) are 
available for online purchase year-round, allowing for more regular consumption 
and in turn requiring fewer fruits per day and/or a shorter time period to reach the 
same amount of overall life-time consumption. Therefore, it is feasible for one to 
ingest high enough levels of annonacin by regularly consuming pawpaw fruit. 
Due to its lipophilic nature,63 it is reasonable to assume that annonacin 
can cross biological membranes and interact with intracellular components. 
Champy and colleagues demonstrated that annonacin can cross the blood brain 
barrier after intravenous administration.5 Though this supports the hypothesis 
that annonacin could reach the brain after fruit consumption, it should be noted 
that the potentially toxic exposure levels discussed above are assumptions 
based on animal studies. Some studies have shown that intraperitoneal injection 
of acetogenins or oral consumption of crude pawpaw extract inhibits tumor 
growth and delay tumor genesis.42,109-111 Though these studies did not evaluate 
post-mortem tissue for the presence of acetogenins, the antiCipated outcome of 
cancer cell death suggests the ability of these compounds to reach cellular 
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targets. Contrarily, rats orally consuming pawpaw extract showed no trace of 
acetogenins in their blood via LC-MS/MS analysis even though the treated rats 
showed a delay in tumor growth compared to untreated controls. 11 Considering 
these limited and conflicting reports, there is a need for detailed pharmacological 
studies to accurately determine the bioavailability of annonacin and other 
acetogenins after oral ingestion in order to truly evaluate the risk of fruit or extract 
consumption. 
In vitro toxicity of annonacin and Asimina triloba organic fruit extract 
Acute annonacin treatment was toxic to cortical neurons (PO) at low 
micromolar concentrations while treatment with the ACG-free extract did not 
affect neuronal viability, indicating that the neurotoxicity of annonacin was not an 
artifact of the extraction process. Furthermore, annonacin was more toxic in the 
presence of cEX than when purified in terms of the amount of annonacin present 
in each treatment, suggesting that multiple acetogenins synergistically affect 
neuronal viability. The presence of bis-tetrahydrofuranyl acetogenins such as 
bullatacin was likely contributing to the neurotoxicity of cEX 1,63 On the other 
hand, cEX as a whole was not more potent than purified annonacin, exemplifying 
the complexity of interactions between numerous similar compounds and their 
cellular target(s). It is possible that the toxicity of cEX was primarily due to 
another acetogenin, such as bullatacin, which itself could be more toxic than 
annonacin. This would explain the difference in LDso values between purified 
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annonacin and annonacin in the presence of cEX. Nonetheless, a synergistic 
effect of multiple acetogenins, including annonacin, cannot be ruled out since all 
acetogenins may share the same binding site.109 The difference in solvents used 
as the vehicle between cEX and annonacin treatments could explain why cEX 
was not wholly more toxic than annonacin alone since the cultures were more 
tolerable of EtOAc than DSMO. However, it is unlikely that there was a 
protective effect of EtOAc since it did not prevent rotenone toxicity. 
Annonacin was less potent in cortical neurons than previously reported in 
mesencephalic and striatal neurons. 37,63 Cortical neurons were utilized for 
toxicity experiments not only because they are generally less sensitive to insult 
than mesencephalic cultures,112 but primarily because they are affected in 
various neurodegenerative diseases.45, 46, 69 Annonacin, among other 
acetogenins, has been shown to inhibit mitochondrial complex-1 ,3, 34, 37, 63,109,113 
which is vital for the production of A TP and a key target of oxidative stress due to 
the generation of reactive oxygen species (ROS). Furthermore, mitochondria act 
as calcium stores that help regulate the levels of intracellular calcium, which must 
be tightly controlled in order to maintain normal neuronal functioning. While 
increased oxidative stress may be detrimental to all neuronal types, substantia 
nigra neurons may be particularly vulnerable due to physiological properties 
distinct to their dopaminergic phenotype. For example, the catabolism of 
dopamine by monoamine oxidase results in the generation of ROS, adding to the 
oxidative burden of these cells.114 Moreover, the intrinsic pace-making activity of 
midbrain neurons may render them more susceptible to calcium excitotoxicity 
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and increase the energy demand in order to maintain intracellular calcium 
homeostasis.115 Midbrain neurons are also much larger than cortical neurons 
with many more afferent synapses and corresponding energy requirements. 116 
These increases in the need for ATP production result in the generation of even 
more ROS making the DA cell even more vulnerable to oxidative stress and ATP 
depletion. Additionally, annonacin has recently been shown to cause an 
increase in intracellular calcium,117 which may be more detrimental to calcium-
sensitive dopaminergic cells than to cortical neurons. Together these factors 
may contribute to the increased vulnerability of dopaminergic neurons to 
mitochondrial toxins and explain the differences between the annonacin potency 
reported here and in previous studies.115,118 
The important experimental difference of cell origins may also explain 
why, contrary to previous reports of annonacin sharing similar potency with 
rotenone,56,63 rotenone was found to be more potent than annonacin in this 
model. Alternatively, one can speculate that the greater toxicity of rotenone may 
be due to its potential interactions with cellular targets other than mitochondrial 
complex-1, such as c-JUN N-terminal protein kinase (JNK), p38 mitogen 
activated protein kinases, phosphatase 2 B (calcineurin), and GSK3~, among 
others. 82,89,92,96,112 For example, Choi and colleagues have shown that the 
neurotoxicity of rotenone is not dependent upon its ability to inhibit complex-1.82 
Additionally, it has been proposed that rotenone may bind at a different site of 
complex-1 than annonaceous acetogenins, which could account for differences 
in potencies.2, 80 The combination of the increased sensitivity of midbrain 
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neurons to oxidative stress and the ability of rotenone to act via other 
mechanisms could explain the descrepancies between annonacin potency here 
and prior reports as well as between annonacin and rotenone in this modeI.82.118-
121 
It was previously determined that, following the cell culture protocol 
described above in Chapter 11,80% or more of cells in the culture are neurons 
(unpublished data). Additionally, Ara-C was added to the cultures in order to 
inhibit the proliferation of non-neuronal cells; therefore, the reported toxicity was 
likely due to the loss of neuronal cells in the culture. Indeed, 
immunocytochemistry showed reduced MAP2 immunoreactivity in annonacin-
treated cultures after 48 hours, indicating toxicity to neuronal cells as MAP2 is a 
neuron-specific marker. To date, As. triloba toxicity has only been evidenced in 
cancer cell lines, and roughly addressed in cancerous murine models. 8 This 
finding of in vitro cortical neurotoxicity corroborates previous reports of annonacin 
neurotoxicity to nigral neurons 5. 37. 55. 56 broadening the significance of 
annonacin-induced toxicity as it relates to neurodegeneration. The neurotoxiCity 
results are particularly interesting considering the cortical neurodegeneration 
seen in a number of diseases including AD, FTD and corticobasal 
degeneration.46. 48. 52. 69 
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In vitro effects of annonacin on microtubule associated protein tau 
The microtubule associated protein tau plays a number of important roles 
involved in maintaining proper neuronal morphology and function. 122 Tau is 
particularly important for regulating microtubule (MT) dynamics, which is crucial 
for neuronal viability. The ability of tau to interact with microtubules is affected by 
its phosphorylation status, with hyperphosphorylation resulting in a decreased 
affinity for MTs.123-126 Likewise, tau may be involved in MT stability and dynamic 
instability with its specific action depending on the isoform, therefore the ratio of 
3R to 4R tau is also vital for neuronal functioning. 127, 128 
Annonacin treatment of cortical neurons resulted in decreased levels of 
total tau (DA9). The annonacin induced decrease in tau protein expression is 
interesting as it was previously shown to cause an increase in both phospho- and 
total tau; however, this was attributed to a decrease in tau degradation rather 
than increased expression since tau messenger ribonucleic acid (mRNA) was 
decreased after annonacin treatment.37 The finding of decreased tau expression 
in conjunction with annonacin neurotoxicity is also interesting considering the 
ongoing debate regarding the role of tau in neurodegenerative pathogenesis. 
While the association of tau aggregation with neurotoxicity has been 
demonstrated,127, 129-131 others propose that the formation of tau aggregates is 
the cells attempt to protect itself from toxic, soluble tau species. 132, 133 Likewise, 
though hyperphosphorylation of tau is undoubtedly an important factor 
contributing to neuronal dysfunction in tauopathy, the mechanism by which this is 
explained remains a topic of debate. Some suggest tau hyperphosphorylation 
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may result in a loss of normal functioning due to an inability to properly bind and 
regulate microtubules.134-136 The observation that paclitaxel, a microtubule 
stabilizing agent, prevented tau-mediated toxicity supports this hypothesis.137 
Contrarily, others show not only is there a lack of evident neurodegeneration or 
neuronal impairment in tau knockout studies, but suggest that reducing tau may 
be neuroprotective122, 138 (and references therein). On the other hand, some 
studies suggest that tau abnormalities, and hence microtubule dysfunction, may 
disrupt mitochondria leading to oxidative stress and cell death.83, 129, 133 As this 
project was intended to evaluate the effect of annonacin on tau phosphorylation, 
the precise mechanistic and temporal relationships between tau reduction and 
cell death cannot be concluded. However, this finding supports the tau "loss of 
function" hypothesis, and the early time-point (4 hours) suggests the loss of tau 
occurs early in the process of annonacin neurotoxicity. 
Though it is plausible that the neurotoxic effects of annonacin 
demonstrated here may be a result of direct action on tau andl or microtubules, 
this explanation is unlikely as it was previously shown that annonacin toxicity 
persisted in the presence of taxol, which stabilized microtubules and prevented 
the somatic redistribution of tau.37 This suggests that annonacin is not directly 
impairing microtubules or causing a toxic loss of function in tau. Alternatively, the 
noticeable changes in tau could be a downstream effect of annonacin induced 
complex-1 inhibition, as previously reported.5, 37, 56, 63 In support of this 
mechanism of action is the observation that mitochondrial inhibition and oxidative 
stress effects tau phosphorylation and reports of impaired mitochondrial 
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dynamics leading to neurodegeneration 137,139,140 (and references therein). 
Fluorescent-labeled synthetic acetogenins have been shown to localize in 
mitochondria,141 further supporting a direct effect on complex-1 with changes in 
tau being secondary. Certainly, tau is an important protein for proper neuronal 
functioning and its dysregulation could be detrimental to the cell; however, the 
results presented here cannot determine whether the decrease in tau is a cause 
or consequence of impaired neuronal functioning. 
At the outset of this project, it was hypothesized that annonacin would 
result in increased tau phosphorylation; therefore, its effect on GSK313 was 
considered due its ability to phosphorylate tau at a number of biologically 
relevant sites and implication in tau pathology.87-89 As expected based on its 
effects on tau, annonacin did not induce a significant change in total or phospho-
GSK313 expression. Though not in support of the initial hypothesis, this finding 
does support the hypothesis that any annonacin-induced changes in tau are 
likely secondary to complex-1 inhibition. 
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CHAPTER V 
STRENGTHS AND LIMITATIONS 
Theugh variability in fruit ripeness was net considered, this project 
capitalized en the availability ef As. triloba fruit pulp as it is typically censumed 
(Le. ripe fruit er cemmercially supplied frezen fruit pulp), and utilized efficient 
extractien and iselatien metheds aleng with multiple analytical techniques to. 
determine the presence and quantificatien ef annenacin. While this methed ef 
precuring annenacin was efficient fer the purpeses ef this study, the develepment 
ef a nevel, large-scale synthesis sheuld be empleyed fer ebtaining quantities 
suitable fer maintaining multiple, engeing bielegical testing. In addition to. the 
petential difficulties in acquiring large ameunts ef biemass fer acetegenin 
extractien and annenacin iselatien, anether limitatien to. precurement via natural 
preduct iselatien is the variability ef quality and quantity ef the final product. A 
new synthetic strategy weuld previde fer a mere standardized precess fer 
ebtaining censistent ameunts ef pure material. 
This study revealed the presence ef annenacin in As. triloba fruit pulp and 
substantiated the neuretexicity ef annenacin as well as the crude, acetegenin-
centaining extract in a different medel system than previeus studies. The crude, 
acetegenin-centaining extract mere clesely represents the cempesitien ef actual 
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consumed fruit and plant products. Hence, the finding of cEX neurotoxicity 
suggests a synergistic effect among acetogenins and provides insight into the 
neurotoxic potential of the fruit, which is important when considering potential 
deleterious effects of using As. triloba products chronically for the treatment of 
cancer. 
The in vitro, acute treatment design of this project precludes any 
conclusions regarding chronic, in vivo toxicity; however, the use of primary 
neuronal cultures provides a reliable system for elucidating potential mechanisms 
of action occurring at the cellular level that should be investigated further. 
Additionally, the use of cortical neurons expands upon the current annonacin 
literature, which, with regard to neurotoxicity, has previously been confined to 
mesencephalic and striatal cultures. Likewise, although nothing can be 
concluded regarding bioavailability of orally consumed fruit from this study, it was 
previously demonstrated that annonacin crosses the blood brain barrier,5, 6 
therefore the neurotoxic effects of annonacin noted here could be exerted in vivo 
as well. As this project was designed to confirm previous findings of annonacin 
induced tau pathology; various other potential mechanisms of action and the 
mode of tau pathology were not considered. Considering the discrepancies 
found here with previous reports of annoancin's effect on tau, re-examination of 
its other noted effects (i.e. complex-1 inhibition) may be warranted to confirm 
prior assumptions of its mechanism of action. Additionally, while this is the first 
report of an annonacin-tetraacetate derivative, this project did not explore the 
effects of annonacin acetylation or other structural modifications on its 
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CONCLUSIONS AND FUTURE CONSIDERATIONS 
In summary, these results established the presence of annonacin in As. 
triloba fruit pulp, determined the cortical neurotoxicity of annonacin as well as 
crude acetogenin-containing fruit extract, and revealed an early decrease in the 
microtubule associated protein tau in response to annonacin treatment. These 
findings corroborate previous reports of annonacin neurotoxicity 5, 37, 55, 56 and 
broaden the potential relevance of annonacin to neurodegenerative diseases 
with cortical pathology. 
Consumption of Pawpaw in the United States could eventually be more 
widespread than that of other annonaceous fruits considering As. triloba is the 
only edible annonaceous fruit that is not confined to tropical areas, grows 
throughout the Eastern United States, is available to consumers all year round 
(e.g . frozen pulp, jam, etc.), is being pushed as an alternative cash-crop to 
tobacco in some states, and is touted for its potential use in alternative medicine 
with Paw-Paw Cell-Reg ™ (an annonacin-containing commercial supplement 
made from pawpaw twig extracts). being marketed as beneficial for overall health 
(www.naturessunshine.com) and as a safe complement to cancer 
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therapy.8, 11,26,142 Therefore, future studies must corroborate the finding of As. 
triloba fruit extract neurotoxicity discussed herein and elaborate on this and other 
reports of annonacin induced tau pathology. 
The two primary directions for the future of As. triloba implicated by the 
findings presented here are 1) in vivo testing of chronic, oral fruit consumption to 
determine the bioavailability and more closely mimic human exposure in order to 
better understand the risks associated with consumption of annonaceous fruits, 
and 2) further elucidating mechanisms of annonacin action and effects on tau in 
order for it to be developed as a potentially novel model neurotoxin specific to 
tauopathy. 
Although not directly translatable to human consumption, when 
considered with previous findings, the results reported here warrant further 
investigation regarding the toxic potential of pawpaw fruit and tree products. 
There are a few reports that acetogenin-containing pawpaw extract is safe and 
tolerable after of oral ingestion as determined by changes in weight of mice and 
beagle dogs; however these studies did not determine the presence of 
acetogenins in specific tissues after consumption.8,42 Champy and colleagues 
have demonstrated the presence of annonacin in the cortices of rats after chronic 
intravenous infusion.s Similar studies should be done after chronic oral ingestion 
to determine if this translates risk to fruit consumption. Likewise, it would be 
insightful for one or multiple studies employing the same methodologies of 
administration and histological examination to consider both the therapeutic (i.e. 
tumor growth inhibition or delay) and neurotoxic effects (i.e. midbrain, striatal and 
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cortical cell loss and tau pathology) of long-term in vivo exposure to acetogenins 
in order to truly model the risks/ benefits of these compounds. Pawpaw 
consumption should also be included in epidemiological studies investigating risk 
factors for neurodegeneration, and its use in alternative medicine further 
scrutinized in order to resolve conflicting epidemiological reports.40, 143 
The moderate lipophilicity of annonacin and other acetogenins likely 
contributes to its ability to cross biological membranes, but may prevent it from 
accessing intracellular targets that are not localized near the cell membrane. 
While studies have suggested how the different acetogenin components (Le 
tetrahydrofuran ring placement, number of hydroxyl groups, hydrocarbon chain 
length, terminal lactone moiety) effect bioactivity, the majority of these have 
focused on their effects on specificity and potencies in various cancer celilines.1, 
109,144-147 It would be interesting to note the effects of structural modifications on 
acetogenin neurotoxicity. Utilizing fluorescently labeled annonaceous 
acetogenins as probes, such as Kojima and colleagues have recently 
synthesized, in combination with time-lapse imaging studies will be valuable in 
further understanding the direct mechanism(s) of action of these compounds.141 
Recent studies have suggested that acetogenins may act as calcium 
chelators, causing increased intracellular calcium and initiating cell death 
mechanisms.32,117 Maintaining calcium homeostasis is vital for neuronal 
signaling, and its dysregulation may be directly involved in neurodegenerative 
mechanisms.148-151 Considering this and its implications in the vulnerability of 
substantia nigra neurons as noted in Chapter IV, future studies should elaborate 
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on the potential for acetogenins to interact with calcium or calcium modulators as 
a primary mechanism of action leading to impaired mitochondrial dynamics and 
tau pathology.117, 144, 150 Similarly, in vivo neurophysiological recordings during 
annonacin treatment could corroborate changes in neuronal calcium flux and 
provide a better understanding of how annonacin is immediately influencing 
neuronal activity.119 Ultimately, a better understanding of acetogenin 
mechanisms and specificity could lead to development of a novel class of 
neurotoxins for use in modeling specific diseases such as PSP and related 
tauopathies or acetogenin derivatives that may be safe and useful in the 
treatment of certain cancers. 
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APPENDIXB: 
EXTRACTION & ISOLATION PROTOCOL 
Extraction of Asimina triloba fruit pulp: 
1) Weigh total amount of fruit pulp (thawed previously) to be extracted 
2) Homogenize pulp with MeOH 
a) 700-800mL of MeOH/1kg of pulp 
b) Record total final volume of all pulp/MeOH homogenate 
3) Let homogenate steep overnight in fridge 
4) Vacuum filter homogenate 
a) Cut fast filter paper to fit filters, use 2 layers of filter paper/ funnel 
b) Soak filter papers with MeOH before adding homogenate 
c) Add 1/2 homogenate to each filter funnel 
d) Filter until cake forms and wash with 50% MeOH (in diH20) 
400mL 50%MeOH/800mL homogenate 
e) Continue filtering until completely dry filter-cakes form 
f) Record weight of filter cake( s) and total vol. of MeOH extracts 
5) Liquid-liquid partitioning with ethyl acetate (EtOAc) 
a) Partition MeOH extracts with 3x200mL ACS grade EtOAc/ 700mL of 
MeOH extracts 
b) In large separatory funnel add: 
-MeOH extracts (700mL) 
-200mL EtOAc 
-100mL brine soln 
-50-100g NaCI 
-1 OOmL diH20 (if needed to dissolve NaCI) 
c) Agitate funnel to be sure contents are mixed well 
d) Allow layers to separate for at least 30min. or until 2 distinct layers have 
formed (record total separation time) 
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e) Empty aqueous (MeOH) layer into large Erlenmyer flask then collect 
organic (EtOAc) layer in another flask & record volume of EtOAc extract 
f) Add aqueous layer back into sep. funnel and add another 200mL EtOAc 
g) Repeat steps d. & e. to have a total of 3x200mL EtOAc partitions 
h) Wash sep. funnel(s) with small amt. of EtOAc & add to collected extracts 
i) Record total amount of EtOAc extracts and note color 
6) Dry EtOAc extracts with anhydrous sodium sulfate (Na2S04) overnight 
under refridgeration 
7) Concentrate EtOAc extracts in recovery flask on rotovap 
a) Filter extracts into recovery flask 
b) Wash Na2S04 with EtOAc and filter wash into recovery flask with 
extracts 
c) Rotovap to dryness & repeat as needed until all extracts are 
concentrated 
d) Record consistency & color of concentrated crude extracts 
8) Remove remaining solvent with high vacuum pump for 3 hours -overnight 
a) Record final weight of dried extract and note consistency and color 
Isolation of annonacin from fruit extracts: 
Use gravity silica gel (Merck, Silica Gel 60 F254) packed to 250mm in a 25mm 
wide column. Volumes used are per -500mg of crude extract. Load crude 
extract in EtOAc adding small amounts of MeOH as needed to fully dissolve 
contents. 
1 ) Gradient solvent system for 1 st column chromatography: 
a) Hexane: EtOAc 5:1 (500ml) 
b) Hexane: EtOAc 1:1 (200ml) 
c) Hexane: EtOAc 1:2 (200ml) 
d) 100% EtOAc (100ml) 
e) 5% MeOH in EtOAc (500ml) 
2) Gradient solvent system for 2nd (and 3rd , if needed) column chromatography: 
a) Hexane: EtOAc 1:1 (200ml) 
b) Hexane: EtOAc 1:2 (300ml) 
c) 5% MeOH in EtOAc (300ml) 
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